The number of productive T cell receptor (TCR)β and TCRγ clonotypes and the Shannon diversity index of TCRβ and TCRγ increased in the posttreatment tumor sample compared with the pretreatment specimen (Fig. 5a). This evidence concerns the gene TRGC1 and neoplasm.